Test Bank -
Pharmacotherapeutics For Advanced Practice: A
Practical Approach,
By Virginia Poole Arcangelo , Andrew Peterson , Veronica Wilbur
5th Edition
, Table Of Contents
Chapter 1 Issues For The Practitioner In Drug Therapy
Chapter 2. Pharmacokinetic Basis Of Therapeutics And Pharmacodynamic
Chapter 3. Impact Of Drug Interactions And Adverse Events On
TherapeuticsChapter 4. Principles Of Pharmacotherapy In Children
Chapter 5. Principles Of Pharmacotherapy In Pregnancy
And Chapter 6. Principles Of Pharmacotherapy In Elderly
PatientsChapter 7 Principles Of Pharmacotherapy In Pain
Chapter 8. Principles Of Antimicrobial Therapy
Chapter 9. Complementary And Alternative
MedicinesChapter 10. Pharmacogenomics
Chapter 11. Contact Dermatitis
Chapter 12. Fungal Infections Of The Skin
Chapter 13 Viral Infections Of The Skin
Chapter 14 Bacterial Infections Of The
SkinChapter 15. Psoriasis
Chapter 16. Acne Vulgaris And
RosaceaChapter 17 Ophthalmic
Disorders Chapter 18 Ophthalmic
Disorders Chapter 19. Hypertension
Chapter 20. Hyperlipidemia
Chapter 21. Angina
Chapter 22. Heart Failure
Chapter 23. Dysrhythmias
Chapter 24 Upper Respiratory Infections
Chapter 25. Asthma
Chapter 26. Chronic Obstructive Pulmonary Disease
Chapter 27. Bronchitis And Pneumonia
Chapter 28. Nausea And Vomiting
Chapter 29. Gastroesophageal Reflux Disease And Peptic Ulcer
DiseaseChapter 30. Constipation Diarrhea And Irritable Bowel
Syndrome Chapter 31 Inflammatory Bowel Disease
Chapter 32. Urinary Tract Infections
Chapter 34. Overactive Bladder
Chapter 35. Sexually Transmitted Infections
Chapter 36. Osteoarthritis And Rheumatoid
ArthritisChapter 37. Fibromyalgia
Ch 38. Headaches
,Chapter 39 Seizure Disorders
Chapter 40. Depressive Disorders
Chapter 41. Depressive Disorders
Chapter 42 Insomnia And Sleep Disorders
Chapter 43. Attention Deficit/Hyperactivity Disorder
Chapter 44. Alzheimer’s Disease
Chapter 45. Diabetes Mellitus
Chapter 46. Thyroid Disorders
Chapter 47. Allergies And Allergic
ReactionsChapter 48. Human
Immunodeficiency VirusChapter 49.
Coagulation Disturbances Chapter 50.
Anemias
Chapter 51. Immunizations Chapter 53. Travel Medications
Chapter 52. Smoking Cessation
Chapter 54. Weight Loss
Chapter 55. Contraception
Chapter 56. Menopause And Menopausal Hormone
TherapyChapter 57. Osteoporosis
Chapter 58 Vaginitis
Chapter 59. The Economics Of Pharmacotherapeutics
Chapter 60. Integrative Approaches To Pharmacotherapy – A Look At Complex Cases
, Chapter 1 Issues For The Practitioner In Drug Therapy
Multiple Choice
1. Nurse Practitioner Prescriptive Authority Is Regulated By:
A. The National Council Of State Boards Of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board Of Nursing For Each State
D. The State Board Of Pharmacy
Ans: C Points: 1
2. Physician Assistant (Pa) Prescriptive Authority Is Regulated By:
A. The National Council Of State Boards Of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board Of Nursing
D. The State Board Of Medical Examiners
Ans: D Points: 1
3. Clinical Judgment In Prescribing Includes:
A. Factoring In The Cost To The Patient Of The Medication Prescribed
B. Always Prescribing The Newest Medication Available For The Disease
Process
C. Handing Out Drug Samples To Poor Patients
D. Prescribing All Generic Medications To Cut Costs
Ans: A Points: 1
4. Criteria For Choosing An Effective Drug For A Disorder Include:
A. Asking The Patient What Drug They Think Would Work Best For Them
B. Consulting Nationally Recognized Guidelines For Disease Management
C. Prescribing Medications That Are Available As Samples Before Writing A
Prescription
D. Following U.S. Drug Enforcement Administration (Dea) Guidelines
Forprescribing
Ans: B Points: 1
5. Nurse Practitioner Practice May Thrive Under Health-Care Reform Due To:
A. The Demonstrated Ability Of Nurse Practitioners To Control Costs And
ImprovePatientoutcomes
B. The Fact That Nurse Practitioners Will Be Able To Practice Independently
C. The Fact That Nurse Practitioners Will Have Full Reimbursement Under
Health-Carereform
D. The Ability To Shift Accountability For Medicaid To The State Level
Ans: A Points: 1
Pharmacotherapeutics For Advanced Practice: A
Practical Approach,
By Virginia Poole Arcangelo , Andrew Peterson , Veronica Wilbur
5th Edition
, Table Of Contents
Chapter 1 Issues For The Practitioner In Drug Therapy
Chapter 2. Pharmacokinetic Basis Of Therapeutics And Pharmacodynamic
Chapter 3. Impact Of Drug Interactions And Adverse Events On
TherapeuticsChapter 4. Principles Of Pharmacotherapy In Children
Chapter 5. Principles Of Pharmacotherapy In Pregnancy
And Chapter 6. Principles Of Pharmacotherapy In Elderly
PatientsChapter 7 Principles Of Pharmacotherapy In Pain
Chapter 8. Principles Of Antimicrobial Therapy
Chapter 9. Complementary And Alternative
MedicinesChapter 10. Pharmacogenomics
Chapter 11. Contact Dermatitis
Chapter 12. Fungal Infections Of The Skin
Chapter 13 Viral Infections Of The Skin
Chapter 14 Bacterial Infections Of The
SkinChapter 15. Psoriasis
Chapter 16. Acne Vulgaris And
RosaceaChapter 17 Ophthalmic
Disorders Chapter 18 Ophthalmic
Disorders Chapter 19. Hypertension
Chapter 20. Hyperlipidemia
Chapter 21. Angina
Chapter 22. Heart Failure
Chapter 23. Dysrhythmias
Chapter 24 Upper Respiratory Infections
Chapter 25. Asthma
Chapter 26. Chronic Obstructive Pulmonary Disease
Chapter 27. Bronchitis And Pneumonia
Chapter 28. Nausea And Vomiting
Chapter 29. Gastroesophageal Reflux Disease And Peptic Ulcer
DiseaseChapter 30. Constipation Diarrhea And Irritable Bowel
Syndrome Chapter 31 Inflammatory Bowel Disease
Chapter 32. Urinary Tract Infections
Chapter 34. Overactive Bladder
Chapter 35. Sexually Transmitted Infections
Chapter 36. Osteoarthritis And Rheumatoid
ArthritisChapter 37. Fibromyalgia
Ch 38. Headaches
,Chapter 39 Seizure Disorders
Chapter 40. Depressive Disorders
Chapter 41. Depressive Disorders
Chapter 42 Insomnia And Sleep Disorders
Chapter 43. Attention Deficit/Hyperactivity Disorder
Chapter 44. Alzheimer’s Disease
Chapter 45. Diabetes Mellitus
Chapter 46. Thyroid Disorders
Chapter 47. Allergies And Allergic
ReactionsChapter 48. Human
Immunodeficiency VirusChapter 49.
Coagulation Disturbances Chapter 50.
Anemias
Chapter 51. Immunizations Chapter 53. Travel Medications
Chapter 52. Smoking Cessation
Chapter 54. Weight Loss
Chapter 55. Contraception
Chapter 56. Menopause And Menopausal Hormone
TherapyChapter 57. Osteoporosis
Chapter 58 Vaginitis
Chapter 59. The Economics Of Pharmacotherapeutics
Chapter 60. Integrative Approaches To Pharmacotherapy – A Look At Complex Cases
, Chapter 1 Issues For The Practitioner In Drug Therapy
Multiple Choice
1. Nurse Practitioner Prescriptive Authority Is Regulated By:
A. The National Council Of State Boards Of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board Of Nursing For Each State
D. The State Board Of Pharmacy
Ans: C Points: 1
2. Physician Assistant (Pa) Prescriptive Authority Is Regulated By:
A. The National Council Of State Boards Of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board Of Nursing
D. The State Board Of Medical Examiners
Ans: D Points: 1
3. Clinical Judgment In Prescribing Includes:
A. Factoring In The Cost To The Patient Of The Medication Prescribed
B. Always Prescribing The Newest Medication Available For The Disease
Process
C. Handing Out Drug Samples To Poor Patients
D. Prescribing All Generic Medications To Cut Costs
Ans: A Points: 1
4. Criteria For Choosing An Effective Drug For A Disorder Include:
A. Asking The Patient What Drug They Think Would Work Best For Them
B. Consulting Nationally Recognized Guidelines For Disease Management
C. Prescribing Medications That Are Available As Samples Before Writing A
Prescription
D. Following U.S. Drug Enforcement Administration (Dea) Guidelines
Forprescribing
Ans: B Points: 1
5. Nurse Practitioner Practice May Thrive Under Health-Care Reform Due To:
A. The Demonstrated Ability Of Nurse Practitioners To Control Costs And
ImprovePatientoutcomes
B. The Fact That Nurse Practitioners Will Be Able To Practice Independently
C. The Fact That Nurse Practitioners Will Have Full Reimbursement Under
Health-Carereform
D. The Ability To Shift Accountability For Medicaid To The State Level
Ans: A Points: 1
